Global Lung Stents Market Forecast 2025-2033: Rising Interventional Pulmonology Adoption to Drive US$ 579.98 Million Valuation at 12.6% CAGR | Top Companies are Boston Scientific Corporation, Cook Medical, ELLA-CS

Global Lung Stents Market Size and Forecast

Global Lung Stents Market reached US$ 175.57 million in 2024 and is expected to reach US$ 579.98 million by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Global Lung Stents Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/lung-stents-market?rk

Recent Developments:
✅ October 2025: Leading interventional pulmonology device manufacturers introduced next-generation self-expanding metallic lung stents designed with enhanced flexibility and anti-migration features. These innovations improve airway patency in patients with malignant and benign airway obstructions, reducing complication rates and improving long-term outcomes.

✅ September 2025: A major respiratory device company launched a fully covered silicone-based airway stent optimized for complex tracheobronchial strictures. The new design focuses on easier deployment and removal, supporting minimally invasive bronchoscopy procedures in tertiary care centers.

✅ August 2025: European healthcare providers reported increased adoption of biodegradable airway stents for temporary airway support. These stents gradually dissolve after restoring airway function, minimizing the need for secondary removal procedures and aligning with patient-centric treatment trends.

✅ June 2025: Manufacturers expanded their customized 3D-printed lung stent solutions for anatomically complex cases. The technology enables patient-specific airway modeling using CT imaging, enhancing precision placement and clinical success rates in advanced thoracic oncology care.

Mergers & Acquisitions:
✅ November 2025: A global medical device company acquired a specialty airway management firm to strengthen its portfolio in interventional pulmonology and bronchoscopic solutions, expanding its presence in high-growth emerging markets.

✅ September 2025: A multinational healthcare technology provider completed the acquisition of a minimally invasive respiratory device startup, integrating advanced stent delivery systems with imaging-guided navigation platforms.

✅ July 2025: A leading endoscopy equipment manufacturer merged with a regional airway implant developer to enhance its silicone and hybrid lung stent product line, supporting broader distribution across Asia-Pacific.

✅ May 2025: A major hospital-focused medical supplier acquired a digital respiratory monitoring company to integrate real-time airway pressure monitoring and post-stent complication tracking into its interventional pulmonology ecosystem.

Key Players:

Boston Scientific Corporation, Cook Medical, ELLA-CS, s.r.o, Merit Medical Systems, Inc., Novatech SA, Micro-Tech (Nanjing) Co., Ltd., S&G Biotech Inc., Medorah Meditek Pvt. Ltd, Mitrai Industries and E. Benson Hood Laboratories, Inc among others.

Growth Forecast Projected:

The Global Global Lung Stents Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Global Lung Stents Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=lung-stents-market?rk

Key Segments:

By Product Type
The market is segmented into Bronchial Stents 45%, Tracheal Stents 40%, and Others 15%, with bronchial stents leading due to their widespread use in managing airway obstructions caused by lung cancer, strictures, and chronic respiratory diseases. Tracheal stents hold a significant share driven by increasing cases of tracheal stenosis and trauma-related airway narrowing. The "others" category includes customized and Y-shaped stents used in complex airway conditions. Rising prevalence of respiratory disorders supports overall segment growth.

By Material
By material, the market includes Metal Stents 50%, Silicone Stents 35%, and Hybrid Stents 15%, with metal stents dominating due to their flexibility, self-expanding properties, and long-term durability. Silicone stents are widely preferred for temporary placements and ease of removal. Hybrid stents are gaining traction as they combine the benefits of metal and silicone, offering improved patient comfort and reduced complication rates. Technological innovation in biocompatible materials drives segment expansion.

By End-User
Based on end-user, the market comprises Hospitals 60%, Specialty Clinics 25%, Ambulatory Surgical Centers 10%, and Others 5%, with hospitals dominating due to availability of advanced bronchoscopy equipment and skilled thoracic surgeons. Specialty clinics contribute significantly through minimally invasive airway procedures. Ambulatory surgical centers are gradually expanding their role due to cost-effective outpatient interventions.

Regional Analysis
North America - 38% Share
North America leads with 38% share due to advanced healthcare infrastructure, high lung cancer prevalence, and strong adoption of minimally invasive pulmonary procedures. The U.S. remains the largest contributor supported by favorable reimbursement policies and technological advancements.

Europe - 27% Share
Europe accounts for 27% share, supported by increasing geriatric population and rising cases of chronic respiratory diseases. Germany, France, and the UK are key markets driven by improved diagnostic capabilities and healthcare access.

Asia Pacific - 22% Share
Asia-Pacific holds 22% share driven by rising air pollution levels, increasing smoking rates, and expanding healthcare facilities in China, India, and Japan. Growing awareness of interventional pulmonology procedures supports regional growth.

Latin America - 7% Share
Latin America captures 7% share, supported by improving healthcare infrastructure and rising incidence of respiratory conditions in Brazil and Mexico.

Middle East & Africa - 6% Share
The Middle East & Africa region holds 6% share, driven by expanding tertiary care hospitals and increasing demand for advanced respiratory treatments in GCC countries and South Africa.

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/lung-stents-market?rk

FAQ

Q1: What is the current size of the Global Lung Stents Market?

A: Lung Stents Market reached US$ 175.57 million in 2024 and is expected to reach US$ 579.98 million by 2033

Q2: How rapidly will the Market expand?

A: The Global Lung Stents market is projected to grow at a CAGR of 12.6 % between 2025 and 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?rk

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.